HRP20010277B1 - Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative - Google Patents

Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative

Info

Publication number
HRP20010277B1
HRP20010277B1 HR20010277A HRP20010277A HRP20010277B1 HR P20010277 B1 HRP20010277 B1 HR P20010277B1 HR 20010277 A HR20010277 A HR 20010277A HR P20010277 A HRP20010277 A HR P20010277A HR P20010277 B1 HRP20010277 B1 HR P20010277B1
Authority
HR
Croatia
Prior art keywords
nitecapone
entacapone
cellulose derivative
well
cross
Prior art date
Application number
HR20010277A
Other languages
English (en)
Croatian (hr)
Inventor
Vahervuo Kari
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22542186&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20010277(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of HRP20010277A2 publication Critical patent/HRP20010277A2/hr
Publication of HRP20010277B1 publication Critical patent/HRP20010277B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
HR20010277A 1998-09-14 2001-04-12 Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative HRP20010277B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/152,263 US6599530B2 (en) 1998-09-14 1998-09-14 Oral compacted composition comprising catechol derivatives
PCT/FI1999/000740 WO2000015196A1 (en) 1998-09-14 1999-09-13 Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative

Publications (2)

Publication Number Publication Date
HRP20010277A2 HRP20010277A2 (en) 2002-06-30
HRP20010277B1 true HRP20010277B1 (en) 2010-10-31

Family

ID=22542186

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20010277A HRP20010277B1 (en) 1998-09-14 2001-04-12 Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative

Country Status (39)

Country Link
US (1) US6599530B2 (es)
EP (1) EP1112065B1 (es)
JP (1) JP4619537B2 (es)
KR (1) KR100732187B1 (es)
CN (1) CN1151778C (es)
AR (1) AR021806A1 (es)
AT (1) ATE256454T1 (es)
AU (1) AU746889B2 (es)
BG (1) BG65041B1 (es)
BR (1) BR9913681A (es)
CA (1) CA2342634C (es)
CO (1) CO5130008A1 (es)
CZ (1) CZ293960B6 (es)
DE (1) DE69913714T2 (es)
DK (1) DK1112065T3 (es)
EA (1) EA003282B1 (es)
EE (1) EE04657B1 (es)
ES (1) ES2213381T3 (es)
GE (1) GEP20033062B (es)
HK (1) HK1039750B (es)
HR (1) HRP20010277B1 (es)
HU (1) HU228910B1 (es)
ID (1) ID29026A (es)
IL (1) IL141681A0 (es)
ME (1) ME00706B (es)
MY (1) MY124394A (es)
NO (1) NO331641B1 (es)
NZ (1) NZ510583A (es)
PE (1) PE20001060A1 (es)
PL (1) PL193454B1 (es)
PT (1) PT1112065E (es)
RS (1) RS49723B (es)
SI (1) SI1112065T1 (es)
SK (1) SK284049B6 (es)
TR (1) TR200100752T2 (es)
TW (1) TWI222367B (es)
UA (1) UA73925C2 (es)
WO (1) WO2000015196A1 (es)
ZA (1) ZA200102084B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI109453B (fi) 1999-06-30 2002-08-15 Orion Yhtymae Oyj Farmaseuttinen koostumus
FI20000635A0 (fi) * 2000-03-17 2000-03-17 Orion Yhtymae Oyj COMT-inhibiittoreiden käyttö analgeettina
US7659253B2 (en) * 2002-02-22 2010-02-09 Shire Llc Abuse-resistant amphetamine prodrugs
US20060173074A1 (en) 2004-11-10 2006-08-03 Juha Ellmen Treatment of restless legs syndrome
SI1896006T1 (sl) * 2005-06-08 2010-02-26 Orion Corp Postopek za izdelavo granul, ki vsebujejo entakapon, za oralne odmerne oblike
AU2012216377C1 (en) * 2005-06-08 2013-10-10 Orion Corporation Oral dosage form
US8772346B2 (en) 2005-11-09 2014-07-08 Torrent Pharmaceuticals Limited Pharmaceutical composition
EP1991241A4 (en) * 2006-02-23 2009-07-08 Iomedix Sleep Internat Srl COMPOSITIONS AND METHODS FOR INTRODUCING AND MAINTAINING HIGH-QUALITY SLEEPING
GB2429645A (en) * 2006-03-10 2007-03-07 Sekhsaria Chemicals Ltd Solid pharmaceutical composition comprising a COMT inhibitor, a starch and a wetting agent
WO2007113371A1 (en) * 2006-03-31 2007-10-11 Iprbox Oy Pharmaceutical composition and preparation method thereof
CA2572004A1 (en) * 2006-12-08 2008-06-08 Bernard Charles Sherman Tablets comprising entacapone and crospovidone
EP1946756A1 (en) * 2007-01-17 2008-07-23 Revotar Biopharmaceuticals AG Use of entacapone in cosmetic, dermatological and pharmaceutical compositions
WO2009098663A1 (en) 2008-02-06 2009-08-13 Wockhardt Research Centre Pharmaceutical compositions of entacapone co-micronized with sugar alcohols
ATE510537T1 (de) * 2008-02-06 2011-06-15 Wockhardt Research Center Pharmazeutische zusammensetzungen von entacapon, levodopa und carbidopa mit verbesserter bioverfügbarkeit
EP2328565B1 (en) * 2008-08-22 2014-06-04 Wockhardt Limited An extended release pharmaceutical composition of entacapone or salts thereof
JP5718937B2 (ja) * 2009-12-25 2015-05-13 イノファーマックス インコーポレイテッド パーキンソン病を治療するための医薬組成物及びその調製方法
WO2012147099A1 (en) 2011-04-25 2012-11-01 Suven Nishtaa Pharma Pvt. Ltd. Pharmaceutical compositions of levodopa, carbidopa and entacapone
EA025627B1 (ru) * 2011-04-26 2017-01-30 Иннофармакс, Инк. Композиция для лечения болезни паркинсона
WO2016083863A1 (en) 2014-11-28 2016-06-02 Bial - Portela & Ca, S.A. Medicaments for slowing parkinson's disease
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
EP3275433A1 (en) * 2016-07-29 2018-01-31 Som Innovation Biotech S.L. Sustained release composition comprising micronized tolcapone
CN106236720A (zh) * 2016-08-29 2016-12-21 海南通用康力制药有限公司 一种恩他卡朋的药物组合物及其制备方法
CN113274362A (zh) * 2021-03-31 2021-08-20 海南通用康力制药有限公司 恩他卡朋片的生产方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5446194A (en) * 1986-11-28 1995-08-29 Orion-Yhtyma Oy Pharmacologically active catechol derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01501934A (ja) * 1986-04-01 1989-07-06 ジ・アップジョン・カンパニー メチルプレドニソロン/カルボキシメチルスターチナトリウム錠剤組成物
YU213587A (en) * 1986-11-28 1989-06-30 Orion Yhtymae Oy Process for obtaining new pharmacologic active cateholic derivatives
US5489614A (en) * 1987-11-27 1996-02-06 Orion-Yhtyma Oy Catechol derivatives, their physiologically acceptable salts, esters and use
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
TW430561B (en) * 1995-12-20 2001-04-21 Gea Farmaceutisk Fabrik As Rapid release tablet composition comprising tolfenamic acid or a pharmaceutically acceptable salt thereof as active ingredient and a method of preparing such tablet

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5446194A (en) * 1986-11-28 1995-08-29 Orion-Yhtyma Oy Pharmacologically active catechol derivatives

Also Published As

Publication number Publication date
IL141681A0 (en) 2002-03-10
ATE256454T1 (de) 2004-01-15
JP2002524493A (ja) 2002-08-06
DE69913714D1 (de) 2004-01-29
EE04657B1 (et) 2006-08-15
RS49723B (sr) 2007-12-31
US20020132009A1 (en) 2002-09-19
SK3072001A3 (en) 2002-05-09
JP4619537B2 (ja) 2011-01-26
NO331641B1 (no) 2012-02-13
CA2342634C (en) 2008-01-29
EA200100354A1 (ru) 2001-08-27
BR9913681A (pt) 2001-06-05
SI1112065T1 (en) 2004-04-30
KR20010075084A (ko) 2001-08-09
HK1039750B (zh) 2005-02-18
NO20011278D0 (no) 2001-03-13
GEP20033062B (en) 2003-09-25
HU228910B1 (en) 2013-06-28
CN1151778C (zh) 2004-06-02
KR100732187B1 (ko) 2007-06-27
PT1112065E (pt) 2004-04-30
EE200100147A (et) 2002-06-17
TWI222367B (en) 2004-10-21
DE69913714T2 (de) 2004-10-07
AR021806A1 (es) 2002-08-07
NZ510583A (en) 2002-09-27
HUP0103454A3 (en) 2003-11-28
WO2000015196A1 (en) 2000-03-23
BG105436A (en) 2001-11-30
CO5130008A1 (es) 2002-02-27
UA73925C2 (uk) 2005-10-17
HK1039750A1 (en) 2002-05-10
ZA200102084B (en) 2002-06-13
HUP0103454A2 (hu) 2002-01-28
US6599530B2 (en) 2003-07-29
AU5748299A (en) 2000-04-03
TR200100752T2 (tr) 2001-10-22
PL346618A1 (en) 2002-02-25
CZ2001792A3 (cs) 2001-08-15
NO20011278L (no) 2001-03-13
PL193454B1 (pl) 2007-02-28
YU19301A (sh) 2003-02-28
ES2213381T3 (es) 2004-08-16
CA2342634A1 (en) 2000-03-23
EA003282B1 (ru) 2003-04-24
BG65041B1 (bg) 2007-01-31
DK1112065T3 (da) 2004-04-05
EP1112065B1 (en) 2003-12-17
AU746889B2 (en) 2002-05-02
PE20001060A1 (es) 2000-10-20
HRP20010277A2 (en) 2002-06-30
MY124394A (en) 2006-06-30
EP1112065A1 (en) 2001-07-04
ME00706B (me) 2007-12-31
SK284049B6 (sk) 2004-08-03
CN1319005A (zh) 2001-10-24
ID29026A (id) 2001-07-26
CZ293960B6 (cs) 2004-08-18

Similar Documents

Publication Publication Date Title
HRP20010277B1 (en) Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative
BR9710372B1 (pt) composto, e, composiÇço farmacÊutica.
IS4963A (is) Setnar 6,5-heteró-bísýklískar afleiður
BR9804500B1 (pt) derivado de amida, referida composição farmacêutica e agente terapêutico.
IS1903B (is) 2-methýl-thíenó-bensódíasepín, samsetning til inntöku
TR199700049A2 (tr) Düsük CO'lu sigara.
ID18352A (id) Komposisi-komposisi farmasi
IT1290383B1 (it) Compressore perfezionato per refrigeranti.
PT1159960E (pt) Composicoes farmaceuticas baseadas em diclofenac
RS49772B (sr) Farmaceutske kompozicije
TR199501082A2 (tr) Farmasötik formülasyonlar.
BRPI9703099B8 (pt) derivado de carboidrato, e, composição farmacêutica
PT941100E (pt) Composicoes farmaceuticas
HRP20000703B1 (en) Stabile compositions levosimendan and alginic acid
DE69636837D1 (de) 1,2,4-benzotriazinoxid-formulierungen
ID16959A (id) Komposisi-komposisi herbisida sinergis lainnya.
TR199700219A3 (tr) 1,25-Dihidroksi-16, 22, 23-Trisdihidro-kolkalsiferol türevleri.
ES1035932Y (es) Adimento para implantes perfeccionado.
IT1290384B1 (it) Compressore perfezionato per refrigeranti.
ZA974422B (en) Substituted-amidinobenzene derivative and pharmaceutical compositions thereof.
DK1190718T3 (da) Oftalmiske sammensætninger, der omfatter aminoalkoholer
TR199500776A2 (tr) Farmasötik bilesimler.
ES1031232Y (es) Compresa quirurgica perfeccionada.
FI972988A0 (fi) Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä
HK1070895A1 (en) Pharmaceutical compositions comprising 2,3 -diarylpyrazolo Ä1,5.bÜpyridazine derivatives

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20180910

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20190913